Παρακολούθηση
Sabesan Yoganathan
Sabesan Yoganathan
Associate Professor, Pharmaceutical Sciences, St. John's University
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα stjohns.edu - Αρχική σελίδα
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
The activity of bacteriocins from Carnobacterium maltaromaticum UAL307 against Gram‐negative bacteria in combination with EDTA treatment
LA Martin‐Visscher, S Yoganathan, CS Sit, CT Lohans, JC Vederas
FEMS microbiology letters 317 (2), 152-159, 2011
1332011
Biosynthesis of aminovinyl-cysteine-containing peptides and its application in the production of potential drug candidates
CS Sit, S Yoganathan, JC Vederas
Accounts of Chemical Research 44 (4), 261-268, 2011
1052011
N-Methylimidazole-catalyzed Synthesis of Carbamates from Hydroxamic Acids via the Lossen Rearrangement
S Yoganathan, SJ Miller
Organic letters 15 (3), 602-605, 2013
822013
Structure diversification of vancomycin through peptide-catalyzed, site-selective lipidation: A catalysis-based approach to combat glycopeptide-resistant pathogens
S Yoganathan, SJ Miller
Journal of medicinal chemistry 58 (5), 2367-2377, 2015
742015
Chemical synthesis and biological evaluation of gallidermin-siderophore conjugates
S Yoganathan, CS Sit, JC Vederas
Organic & Biomolecular Chemistry 9 (7), 2133-2141, 2011
692011
Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment
NS Kulkarni, V Parvathaneni, SK Shukla, L Barasa, JC Perron, ...
European Journal of Pharmaceutical Sciences 133, 145-159, 2019
592019
Synthesis and in vitro evaluation of 18F-and 19F-labeled insulin: a new radiotracer for PET-based molecular imaging studies
KJ Guenther, S Yoganathan, R Garofalo, T Kawabata, T Strack, R Labiris, ...
Journal of medicinal chemistry 49 (4), 1466-1474, 2006
522006
Ellagic Acid and Schisandrins: Natural Biaryl Polyphenols with Therapeutic Potential to Overcome Multidrug Resistance in Cancer
S Yoganathan, A Alagaratnam, N Acharekar, J Kong
Cells 10 (2), 458, 2021
452021
Ciprofloxacin Enhances the Chemosensitivity of Cancer Cells to ABCB1 Substrates
P Gupta, HL Gao, YV Ashar, NM Karadkhelkar, S Yoganathan, ZS Chen
International Journal of Molecular Sciences 20 (2), 268, 2019
372019
Chemical Space Exploration around Thieno[3,2-d]pyrimidin-4(3H)-one Scaffold Led to a Novel Class of Highly Active Clostridium difficile Inhibitors
X Shao, A AbdelKhalek, NS Abutaleb, UK Velagapudi, S Yoganathan, ...
Journal of medicinal chemistry 62 (21), 9772-9791, 2019
302019
Evaluation of copper (I)-doped zinc oxide composite nanoparticles on both gram-negative and gram-positive bacteria
J Kong, S Zhang, M Shen, J Zhang, S Yoganathan
Colloids and Surfaces A: Physicochemical and Engineering Aspects 643, 128742, 2022
242022
Exploration of antibiotic activity of aminoglycosides, in particular ribostamycin alone and in combination with ethylenediaminetetraacetic acid against pathogenic bacteria
J Kong, ZX Wu, L Wei, ZS Chen, S Yoganathan
Frontiers in microbiology 11, 1718, 2020
192020
An efficient one-pot conversion of carboxylic acids into benzimidazoles via an HBTU-promoted methodology
L Barasa, S Yoganathan
RSC Advances 8 (62), 35824-35830, 2018
192018
Synthesis of N-1′, N-3′-disubstituted spirohydantoins and their anticonvulsant activities in pilocarpine model of temporal lobe epilepsy
C Yang, FAX Schanne, S Yoganathan, RA Stephani
Bioorganic & medicinal chemistry letters 26 (12), 2912-2914, 2016
172016
Preclinical development of a novel BCR-ABL T315I inhibitor against chronic myeloid leukemia
P Gupta, GN Zhang, AM Barbuti, X Zhang, N Karadkhelkar, J Zhou, ...
Cancer Letters 472, 132-141, 2020
152020
Repurposing N, N-Dimethylacetamide (DMA), a Pharmaceutical Excipient, as a Prototype Novel Anti-inflammatory Agent for the Prevention and/or Treatment of Preterm Birth
S Gorasiya, J Mushi, R Pekson, S Yoganathan, SE Reznik
Current pharmaceutical design 24 (9), 989-992, 2018
142018
MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter: In vitro and in vivo study
ZX Wu, QX Teng, Y Yang, N Acharekar, JQ Wang, M He, S Yoganathan, ...
Acta Pharmaceutica Sinica B 12 (5), 2609-2618, 2022
122022
An efficient chemical synthesis of carboxylate-isostere analogs of daptomycin
S Yoganathan, N Yin, Y He, M Mesleh, YG Gu, SJ Miller
Org. Biomol. Chem. 11, 4680-4685, 2013
112013
Fracturing rings to understand lantibiotics
S Yoganathan, JC Vederas
Chemistry & biology 15 (10), 999-1001, 2008
102008
The Spleen Tyrosine Kinase Inhibitor, Entospletinib (GS-9973) Restores Chemosensitivity in Lung Cancer Cells by Modulating ABCG2-mediated Multidrug Resistance
S Narayanan, ZX Wu, JQ Wang, H Ma, N Acharekar, J Koya, ...
International journal of biological sciences 17 (10), 2652, 2021
72021
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20